Table 4.
Distribution of human leukocyte antigen-Cw (HLA-Cw) in patients with chronic hepatitis C according to their response to interferon-α therapy
| Sustained virological response in patients with a given allele |
||
|---|---|---|
| HLA | yes (n = 55) | no (n = 57) |
| Cw 1 | 6 | 13 |
| Cw 2 | 9 | 11 |
| Cw 3 | 8 | 12 |
| Cw 4 | 8 | 5 |
| Cw 5 | 9 | 6 |
| Cw 6 | 5 | 10 |
| Cw 7 | 27* | 7* |
| Cw 8 | 3 | 6 |
| Cw 9 | 0 | 2 |
| Cw 11 | 0 | 1 |
| Cw 12 | 15 | 10 |
| Cw 14 | 2 | 3 |
| Cw 15 | 2 | 6 |
| Cw 16 | 3 | 6 |
| Cw 17 | 2 | 3 |
| Cw 19 | 1 | 0 |
| Cw 20 | 0 | 1 |
| Cw 23 | 0 | 1 |
| Cw 25 | 0 | 1 |
*Significant difference between patients with and without sustained virological response (χ2 test = 19.78; P = 0.011).